Artificial intelligence identifies anti-aging drug candidates targeting 'zombie' cells

A new publication in the May issue of Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, demonstrates the power of artificial intelligence (AI) to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.

from Phys.org - latest science and technology news stories https://ift.tt/6kTaKPG